Ryan Specialty Drops 1.16% on Growth Concerns, Hits 2025 Low

Ryan Specialty (RYAN) shares fell 1.16% today, marking the second consecutive day of decline, with a total drop of 3.52% over the past two days. The stock price hit its lowest level since April 2025, experiencing an intraday decline of 1.72%.

The strategy of buying RYAN shares after they reached a recent low and holding for one week resulted in a 56.37% return over the past five years. This outperformed the benchmark, which had a return of -100.00%, resulting in an excess return of 156.37%. The strategy also had a maximum drawdown of 0.00%, a Sharpe ratio of 0.70, and a volatility of 27.92%.

Barclays recently adjusted its target price for Ryan Specialty, lowering it from $83.00 to $79.00 while maintaining an "overweight" rating. This adjustment reflects a more cautious outlook on the company's future performance, despite the continued positive rating.

Ryan Specialty Holdings Inc. is currently facing a negative outlook, primarily driven by decelerating organic growth. This slowdown in growth has raised concerns among investors and analysts, contributing to the recent decline in the stock price.

Wells Fargo analyst Elyse Greenspan has also revised her rating for Ryan Specialty, maintaining an "Equal-Weight" rating but lowering the price target from $65 to $63. This adjustment further underscores the cautious sentiment surrounding the company's stock, as analysts continue to reassess their expectations for future performance.